• nybjtp

I-Groundbreaking Advances kuNyango lwe-Alzheimer: Ukuvunywa kwe-Donanemab kuzisa ithemba elitsha

Ulawulo lokutya kunye neziyobisi lwase-US kutshanje lwenze inyathelo elibalulekileyo kumlo ochasene nesifo se-Alzheimer ngokuvuma idonanemab, i-monoclonal antibody eyenziwe ngu-Eli Lilly.Ithengiswe phantsi kwegama elithi Kisunla, olu nyango lunolutsha lujolise ekunciphiseni ukuqhubela phambili kwesifo se-Alzheimer's symptomatic ngokunceda umzimba ukuba ususe i-amyloid plaque buildup kwingqondo-uphawu lwe-Alzheimer's.Oku kwamkelwa akubonisi nje ixesha elibalulekileyo kuphando lwe-Alzheimer kodwa ikwaqaqambisa ukubaluleka kokubhaqwa kwangethuba kunye nokungenelela.

1 (1) (1)

I-Kisunla: Isahluko esitsha kuNyango lwe-Alzheimer

UDonanemab, okanye iKisunla, ayilonyango lwe-Alzheimer's kodwa ibonise iziphumo ezithembisayo kulingo lwezonyango.Abathathi-nxaxheba abathatha i-Kisunla bafumana i-35% yengozi ephantsi yokuqhubela phambili kwesifo kwiinyanga ze-18 xa kuthelekiswa nalawo akwi-placebo.Oku kuthetha ukuba izigulane zinokuphila ngokuzimeleyo kwaye zibandakanyeke ngokukhuselekileyo kwimisebenzi yemihla ngemihla ixesha elide.

Nangona kunjalo, kubalulekile ukuqaphela ukuba unyango alunayo ingozi.Ngokumalunga ne-2% yabathathi-nxaxheba bafumana iziganeko ezimbi ezinzulu, ezibandakanya i-amyloid-related imaging abnormalities (ARIA), enokukhokelela kwi-micro-hemorrhages engqondweni.Ngaphandle kwale mingcipheko, abacebisi be-FDA baluthathe unyango lukhuselekile kwaye lusebenza, xa benikwa izibonelelo ezinokubakho.

Ukubaluleka Kokufunyanwa Kwangethuba

Ukufunyaniswa kwangoko kunye nokuxilongwa kubalulekile kunyango olusebenzayo lwe-Alzheimer's.I-Kisunla isebenza kakuhle kumanqanaba okuqala eempawu, ikhuthaza u-Eli Lilly ukuba asebenzisane neminye imibutho ukunyusa iindlela zokubona kwangaphambili.Eli nyathelo lihambelana nesidingo esikhulayo sokungenelela kwangoko, ngakumbi njengoko inani leemeko ze-Alzheimer's kuqikelelwa ukuba lifikelele phantse kwi-14 yezigidi ngo-2060.

Indima yoKhathalelo lwaseKhaya kuLawulo lwe-Alzheimer

Njengoko isifo sika-Alzheimer sisiya sihambela phambili, indima yabanonopheli iya ibaluleke ngakumbi.Abalindi bamakhaya, ababonelela ngononophelo kunye nenkxaso rhoqo, badlala indima ebalulekileyo ekuqinisekiseni ukhuseleko kunye nokuphila kakuhle kwezigulane ze-Alzheimer's.Kwiintsapho ezilawula i-Alzheimer's ekhaya, iimveliso ezifana nezo zibonelelwa yi-LIREN Healthcare zinokuxabiseka.

I-LIREN yezempilo igxile kwiimveliso eziphezulu zezempilo ezenzelwe ukomeleza ukhuseleko lwasekhaya kunye nokusebenza kakuhle.Uluhlu lwethu lubandakanya ibhedi kunye noxinzelelo lwesituloiipads sensor, isilumkisoiipagers, kwayeukufowunela amaqhosha, zonke eziyimfuneko ekudaleni indawo ekhuselekileyo nekhuselekileyo yekhaya kubantu abadala.

Ukuphucula uKhuseleko lwaseKhaya kunye neeMveliso zezempilo ze-LIREN

I-1.IiPads zeSensor ye-Pressure: Ezi pads zibekwe kwiibhedi okanye izitulo ukujonga ukunyakaza kunye nokukhangela xa umntu ophezulu ephakama, ngaloo ndlela ekhusela ukuwa.

2.Abenzi beAlerting Pagers: Ezi zixhobo zazisa abo banyamekela abantu ngokukhawuleza xa umntu omdala efuna uncedo, ukuqinisekisa ukuphendula ngokukhawuleza kunye nokunciphisa ingozi yeengozi.

Amaqhosha e-3.Call: Ezi zivumela abantu abadala ukuba bacele uncedo ngokushicilela okulula, ukunika uxolo lwengqondo zombini izigulane kunye nabakhathaleli babo.

Ngokudibanisa iimveliso ze-LIREN zokhathalelo lwempilo kwindawo yokhathalelo lwekhaya, iintsapho zinokudala indawo ekhuselekileyo kwabo babathandayo.Kulabo bacinga ukufaka inkqubo ye-alarm yokhuseleko, ukubandakanya i-sensor sensor pads kunye ne-alerting pagers ingaba yongezwa ngokubalulekileyo kwindlela yokujonga ikhaya.

Ukhuseleko Noxolo Lwengqondo

Ukufakela inkqubo yokhuseleko ebandakanya iimveliso ze-LIREN zezempilo zinokunyusa kakhulu ukhuseleko kunye nokhuseleko lwesigulane se-Alzheimer ekhaya.Inkqubo yethu yokufakela inkqubo ye-alarm yokhuseleko iqondile kwaye yenzelwe ukubonelela ngokhuseleko oluphezulu kunye nokuphazamiseka okuncinci.

1 (2)

Ukujonga Phambili

Ukuvunywa kwe-Kisunla kubonisa ukuqhubela phambili okubalulekileyo kunyango lwe-Alzheimer, enika ithemba elitsha kwizigidi ezichatshazelwa sesi sifo sibi.Njengoko siqhubeka siphonononga kwaye siphuhlisa unyango olutsha, indima yokhathalelo lwasekhaya kunye neemveliso ezintsha ezifana nezo zisuka kwi-LIREN Healthcare ziya kubaluleka kakhulu ekulawuleni isifo se-Alzheimer.

Ukufumana ulwazi oluthe kratya malunga nendlela iimveliso ze-LIREN zokhathalelo lwempilo ezinokukunceda ngayo wenze indawo ekhuselekileyo yasekhaya kwabo ubathandayo, ndwendwela iwebhusayithi yethu.Hlala unolwazi malunga nophuhliso lwamva nje kukhathalelo lwempilo ephezulu kwaye ufumane ezona zisombululo zokuphucula umgangatho wobomi babantu abadala.

Isishwankathelo

Idabi elichasene ne-Alzheimer likude, kodwa ngokuphumelela okufana ne-Kisunla kunye nenkxaso eqhubekayo yeemveliso zokunakekelwa kwekhaya kwiinkampani ezifana ne-LIREN Healthcare, kukho ithemba lekamva elingcono.Njengoko sisamkela ezi nkqubela-phambili zintsha, ukuqinisekisa ukhuseleko kunye nokuphila kakuhle kwezigulana ze-Alzheimer kuhlala kungumba ophambili wethu ophambili.

Ndwendwela iwebhusayithi ye-LIREN Healthcare namhlanje ukuze ufunde ngakumbi malunga neemveliso zethu kunye nendlela ezinokukunceda ngayo wenze indawo yokuhlala ekhuselekileyo, ekhuseleke ngakumbi yekhaya kwabo ubathandayo.Hlala unxibelelene nathi ngeendaba zamva nje kunye nohlaziyo lwezempilo eziphezulu.

Umthombo weendaba:https://edition.cnn.com/2024/07/02/health/lilly-azheimers-donanemab-fda/index.html

I-LIREN ifuna ngokukhutheleyo abasasazi ukuba basebenzisane nabo kwiimarike eziphambili.Abo banomdla bayakhuthazwa ukuba baqhagamshelane ngecustomerservice@lirenltd.comiinkcukacha ezithe vetshe.


Ixesha lokuposa: Jul-08-2024